Quetta Acquisition Corp enters LOI with clinical-stage therapeutics target; deadline extended to Jan 2025

Quetta Acquisition Corp

Entered non-binding LOI with a clinical-stage therapeutics company for a potential business combination.
Deadline to complete initial business combination automatically extended to January 11, 2025 due to LOI.
LOI is non-binding; no definitive agreement exists and no terms disclosed.
Target is a clinical-stage therapeutics company; name and valuation not provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.